Generic Medication Availability and Clinical Equivalence

Patent Expiration and Generic Entry

• Generic medications become available once the original manufacturer's patent expires, typically after a 20-year monopoly period that allows the brand-name company to recoup development costs 1
• When patents expire, other manufacturers can produce generic versions, and the medication price drops substantially 1
• This pattern has occurred with numerous high-revenue medications, including major cardiovascular and psychiatric drugs 1

Cost Implications

• Generic medications typically cost substantially less than brand-name versions while maintaining therapeutic equivalence 1
• Many pharmacy chains offer generic medications for $5 or less per month, representing significant cost savings compared to brand-name pricing 1
• The broad adoption of generic medications when clinically appropriate offers a clear way to improve healthcare value without compromising outcomes 1

Important Clinical Considerations

• The abuse-deterrent properties of lisdexamfetamine stem from its prodrug structure requiring enzymatic conversion in red blood cells, not from proprietary formulation—generic versions retain this same reduced abuse potential 2